You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes and explain in detail?
The Amsterdam et al 2014 AHA/ACC NSTE-ACS Guideline provides an overview of the diagnosis and management of non-ST-segment elevation acute coronary syndrome (NSTE-ACS). It covers topics such as the definition of terms, epidemiology and pathogenesis, clinical assessment and initial evaluation, diagnosis of NSTE-ACS, prognosis and early risk stratification, cardiac biomarkers and the universal definition of myocardial infarction, immediate management, standard medical therapies, inhibitors of the renin-angiotensin-aldosterone system, initial antiplatelet/anticoagulant therapy, and ischemia-guided strategy versus early invasive strategies. It was developed by a 15-member task force and endorsed by the American Association for Clinical Chemistry.